Methylation of MGMT in malignant pleural mesothelioma occurs in a subset of patients and is associated with the T allele of the rs16906252 MGMT promoter SNP

Lung Cancer

Volumn 71, Issue 2, 2011, Pages 130-136

  Kristensen, Lasse Sommer ^a   Nielsen, Helene Myrtue ^a   Hager, Henrik ^b   Hansen, Lise Lotte ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

DNA methylation; Mesothelioma; MGMT; SMART MSP

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ALLELE; ARTICLE; DNA METHYLATION; GENE SILENCING; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MELTING POINT; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 78650953062     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.05.008     Document Type: Article

References (27)

1. Robinson B.W., Lake R.A. Advances in malignant mesothelioma. N Engl J Med 2005, 353:1591-1603.
2. Tsao A.S., Wistuba I., Roth J.A., Kindler H.L. Malignant pleural mesothelioma. J Clin Oncol 2009, 27:2081-2090.
3. Hawkins N.J., Lee J.H., Wong J.J., Kwok C.T., Ward R.L., Hitchins M.P. MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Mod Pathol 2009.
4. Palmisano W.A., Divine K.K., Saccomanno G., Gilliland F.D., Baylin S.B., Herman J.G., et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000, 60:5954-5958.
5. Esteller M., Garcia-Foncillas J., Andion E., Goodman S.N., Hidalgo O.F., Vanaclocha V., et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000, 343:1350-1354.
6. Hegi M.E., Diserens A.C., Gorlia T., Hamou M.F., de Tribolet N., Weller M., et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005, 352:997-1003.
7. Ogino S., Hazra A., Tranah G.J., Kirkner G.J., Kawasaki T., Nosho K., et al. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Carcinogenesis 2007, 28:1985-1990.
8. Kristensen L.S., Hansen L.L. PCR-based methods for detecting single-locus DNA methylation biomarkers in cancer diagnostics, prognostics, and response to treatment. Clin Chem 2009, 55:1471-1483.
9. Kristensen L.S., Mikeska T., Krypuy M., Dobrovic A. Sensitive melting analysis after real time-methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res 2008, 36:e42.
10. Candiloro I.L., Dobrovic A. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res (Phila Pa) 2009, 2:862-867.
11. Kristensen L.S., Wojdacz T.K., Thestrup B.B., Wiuf C., Hager H., Hansen L.L. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. BMC Cancer 2009, 9:453.
12. Hansen L.L., Andersen J., Overgaard J., Kruse T.A. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. APMIS 1998, 106:371-377.
13. Kristensen L.S., Dobrovic A. Direct genotyping of single nucleotide polymorphisms in methyl metabolism genes using probe-free high-resolution melting analysis. Cancer Epidemiol Biomarkers Prev 2008, 17:1240-1247.
14. Liew M., Pryor R., Palais R., Meadows C., Erali M., Lyon E., et al. Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. Clin Chem 2004, 50:1156-1164.
15. Weisenberger D.J., Campan M., Long T.I., Kim M., Woods C., Fiala E., et al. Analysis of repetitive element DNA methylation by MethyLight. Nucleic Acids Res 2005, 33:6823-6836.
16. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
17. Dobrovic A., Kristensen L.S. DNA methylation, epimutations and cancer predisposition. Int J Biochem Cell Biol 2009, 41:34-39.
18. Chan T.L., Yuen S.T., Kong C.K., Chan Y.W., Chan A.S., Ng W.F., et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 2006, 38:1178-1183.
19. Ligtenberg M.J., Kuiper R.P., Chan T.L., Goossens M., Hebeda K.M., Voorendt M., et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 2009, 41:112-117.
20. Suter C.M., Martin D.I. Inherited epimutation or a haplotypic basis for the propensity to silence?. Nat Genet 2007, 39:573. (author reply 576).
21. Suter C.M., Martin D.I., Ward R.L. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 2004, 36:497-501.
22. Hitchins M.P., Wong J.J., Suthers G., Suter C.M., Martin D.I., Hawkins N.J., et al. Inheritance of a cancer-associated MLH1 germ-line epimutation. N Engl J Med 2007, 356:697-705.
23. Tsou J.A., Shen L.Y., Siegmund K.D., Long T.I., Laird P.W., Seneviratne C.K., et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer 2005, 47:193-204.
24. Shen L., Kondo Y., Rosner G.L., Xiao L., Hernandez N.S., Vilaythong J., et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005, 97:1330-1338.
25. Clark S.J., Melki J. DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene 2002, 21:5380-5387.
26. Tsou J.A., Galler J.S., Wali A., Ye W., Siegmund K.D., Groshen S., et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 2007, 58:220-230.
27. Lazcoz P., Munoz J., Nistal M., Pestana A., Encio I.J., Castresana J.S. Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma. Cancer Genet Cytogenet 2007, 174:1-8.